Yu-Chi Chen

Yu-Chi Chen

Auto-generated profile, based on publicly available information

Yu-Chi Chen

Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Biofabrication
Verified
Journal Article
Closed access
OJOlive Jung
Olive Jung
YTYen-Ting Tung
Yen-Ting Tung
ESEsther Sim
Esther Sim
YCYu-Chi Chen
Yu-Chi Chen
ELEmily Lee
Emily Lee
MSMin Jae Song
Min Jae Song
The COVID-19 pandemic has highlighted the need for human respiratory tract-based assay platforms for efficient discovery and development of antivirals and disease-modulating therapeutics. Physiologically relevant tissue models of the lower respiratory tract (LRT), including the respiratory bronchioles and the alveolar sacs, are of high interest because they are the primary site of severe SARS-CoV-2 infection and are most affected during the terminal stage of COVID-19. Current epithelial lung models used to study respiratory viral infections include lung epithelial cells at the air–liquid interface (ALI) with fibroblasts and endothelial cells, but such models do not have a perfusable microvascular network to investigate both viral infectivity and viral infection-induced thrombotic events. Using a high throughput, 64-chip microfluidic plate-based platform, we have developed two novel vascularized, LRT multi-chip models for the alveoli and the small airway. Both models include a perfusable microvascular network consisting of human primary microvascular endothelial cells, fibroblasts and pericytes. The established biofabrication protocols also enable the formation of differentiated lung epithelial layers at the ALI on top of the vascularized tissue bed. We validated the physiologically relevant cellular composition, architecture and perfusion of the vascularized lung tissue models using fluorescence microscopy, flow cytometry, and electrical resistance measurements. These vascularized, perfusable microfluidic lung tissue on high throughput assay platforms will enable the development of respiratory viral infection and disease models for research investigation and drug discovery.

5 August 2025 in Antiviral Research
Verified
Journal Article
Closed access
AMAngelica Medina
Angelica Medina
YCYu-Chi Chen
Yu-Chi Chen
JZJiajing Zhang
Jiajing Zhang
SOSarah C. Ogden
Sarah C. Ogden
SCSamantha Cotsmire
Samantha Cotsmire
ELEmily Lee
Emily Lee